Buy Catabasis Pharmaceuticals Stock | CATB Stock Price & Latest News | Public.com
CATB

Catabasis Pharmaceuticals

$0.00 (0.00%)Today
    Small Market Cap
    View Catabasis Pharmaceuticals (CATB) stock trends here

    About CATB

    Catabasis Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is edasalonexent, which is intended for the treatment of Duchenne muscular dystrophy. The company was founded by Michael R. Jir...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.19
    -0.37
    -0.56
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.30

    Actual EPS
    Q1 2021

    Stats

    Market Cap$57,84M
    Volume150,77k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$8.59
    1 Year Low$1.25
    Open$2.98
    High$3.03
    Low$2.88

    Buy any stock with any amount of money.

    Download the App
    Download the app